Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: MMR at 6 Months Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the measles-mumps-rubella vaccine completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Meales-mumps-rubella Vaccine | Phase 4 | Status: COMPLETED